NAFDAC warns importers, distributors to discontinue sales, use of Lefin Pediatric Suspension drug

The National Agency for Food and Drug Administration and Control (NAFDAC), has warned importers, distributors, and consumers to discontinue the sale and use of Lefin Pediatric Suspension drug with immediate effect.

The agency, on Sunday in a public alert with No. 0047/2021, also asked consumers to hand over the remaining stock of the drug to the nearest NAFDAC office.

According to the alert, NAFDAC has been informed by Drug Regulatory Authority of Pakistan (DRAP) about a recent recall of Lefin Pediatric Suspension manufactured by M/S Leama Chemi Pharma (PVT) Limited for being substandard.

The alert disclosed that Lefin Pediatric suspension is a brand of Paracetamol used for the relief of mild to moderate pain such as headache, muscle aches, toothache as well as pain caused by cold, flu, and sprains.

“NAFDAC implores importers, distributors, and consumers in possession of the recalled lots of Lefin Pediatric Suspension to discontinue sale or use and hand over the remaining stock to the nearest NAFDAC office.

“Health professionals and patients are encouraged to report adverse events or quality problems experienced with the use of these medicines to the nearest NAFDAC office.

“The public could also make use of NAFDAC PRASCOR [20543 or 0800-1-NAFDAC (0800-1-623322) or its TOLL FREE from all networks] or via pharmacovigilance@nafdac.gov.ng.

“The public is also required to make use of the e-Reporting platform available on the NAFDAC website www.nafdac.gov.ng or via Med Safety application available for download on Android and IOS stores.

Leave a Reply

Your email address will not be published.